Literature DB >> 12573760

Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.

Yvette Seppenwoolde1, Joos V Lebesque, Katrien de Jaeger, José S A Belderbos, Liesbeth J Boersma, Cees Schilstra, George T Henning, James A Hayman, Mary K Martel, Randall K Ten Haken.   

Abstract

PURPOSE: To compare different normal tissue complication probability (NTCP) models to predict the incidence of radiation pneumonitis on the basis of the dose distribution in the lung. METHODS AND MATERIALS: The data from 382 breast cancer, malignant lymphoma, and inoperable non-small-cell lung cancer patients from two centers were studied. Radiation pneumonitis was scored using the Southwestern Oncology Group criteria. Dose-volume histograms of the lungs were calculated from the dose distributions that were corrected for dose per fraction effects. The dose-volume histogram of each patient was reduced to a single parameter using different local dose-effect relationships. Examples of single parameters were the mean lung dose (MLD) and the volume of lung receiving more than a threshold dose (V(Dth)). The parameters for the different NTCP models were fit to patient data using a maximum likelihood analysis.
RESULTS: The best fit resulted in a linear local dose-effect relationship, with the MLD as the resulting single parameter. The relationship between the MLD and NTCP could be described with a median toxic dose (TD(50)) of 30.8 Gy and a steepness parameter m of 0.37. The best fit for the relationship between the V(Dth) and the NTCP was obtained with a D(th) of 13 Gy. The MLD model was found to be significantly better than the V(Dth) model (p <0.03). However, for 85% of the studied patients, the difference in NTCP calculated with both models was <10%, because of the high correlation between the two parameters. For dose distributions outside the range of the studied dose-volume histograms, the difference in NTCP, using the two models could be >35%. For arbitrary dose distributions, an estimate of the uncertainty in the NTCP could be determined using the probability distribution of the parameter values of the Lyman-Kutcher-Burman model.
CONCLUSION: The maximum likelihood method revealed that the underlying local dose-effect relation for radiation pneumonitis was linear (the MLD model), rather than a step function (the V(Dth) model). Thus, for the studied patient population, the MLD was the most accurate predictor for the incidence of radiation pneumonitis.

Entities:  

Mesh:

Year:  2003        PMID: 12573760     DOI: 10.1016/s0360-3016(02)03986-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  103 in total

1.  Analysis of dose-volume parameters predicting radiation pneumonitis in patients with esophageal cancer treated with 3D-conformal radiation therapy or IMRT.

Authors:  Gaurav Kumar; Sheh Rawat; Abhishek Puri; Manoj Kumar Sharma; Pranav Chadha; Anand Giri Babu; Girigesh Yadav
Journal:  Jpn J Radiol       Date:  2011-12-14       Impact factor: 2.374

2.  Spanish radiobiological pattern of care in lung cancer: a GOECP/SEOR study.

Authors:  J A González; M Chust; R Delgado; A Gómez; N Rodríguez; M J Ruiz; F Casas
Journal:  Clin Transl Oncol       Date:  2010-04       Impact factor: 3.405

3.  4DCT-based measurement of changes in pulmonary function following a course of radiation therapy.

Authors:  Kai Ding; John E Bayouth; John M Buatti; Gary E Christensen; Joseph M Reinhardt
Journal:  Med Phys       Date:  2010-03       Impact factor: 4.071

Review 4.  21 years of biologically effective dose.

Authors:  J F Fowler
Journal:  Br J Radiol       Date:  2010-07       Impact factor: 3.039

5.  LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective.

Authors:  S Adebahr; S Collette; E Shash; M Lambrecht; C Le Pechoux; C Faivre-Finn; D De Ruysscher; H Peulen; J Belderbos; R Dziadziuszko; C Fink; M Guckenberger; C Hurkmans; U Nestle
Journal:  Br J Radiol       Date:  2015-04-15       Impact factor: 3.039

Review 6.  Radiation dose-volume effects in the lung.

Authors:  Lawrence B Marks; Soren M Bentzen; Joseph O Deasy; Feng-Ming Spring Kong; Jeffrey D Bradley; Ivan S Vogelius; Issam El Naqa; Jessica L Hubbs; Joos V Lebesque; Robert D Timmerman; Mary K Martel; Andrew Jackson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

7.  Does transforming growth factor-beta1 predict for radiation-induced pneumonitis in patients treated for lung cancer?

Authors:  Elizabeth S Evans; Zafer Kocak; Su-Min Zhou; Daniel A Kahn; Hong Huang; Donna R Hollis; Kim L Light; Mitchell S Anscher; Lawrence B Marks
Journal:  Cytokine       Date:  2006-09-18       Impact factor: 3.861

8.  Heart irradiation as a risk factor for radiation pneumonitis.

Authors:  Ellen X Huang; Andrew J Hope; Patricia E Lindsay; Marco Trovo; Issam El Naqa; Joseph O Deasy; Jeffrey D Bradley
Journal:  Acta Oncol       Date:  2010-09-28       Impact factor: 4.089

9.  Combining multiple models to generate consensus: application to radiation-induced pneumonitis prediction.

Authors:  Shiva K Das; Shifeng Chen; Joseph O Deasy; Sumin Zhou; Fang-Fang Yin; Lawrence B Marks
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

10.  Incidence and correlates of radiation pneumonitis in pediatric patients with partial lung irradiation.

Authors:  Chiaho Hua; Kelly A Hoth; Shengjie Wu; Larry E Kun; Monika L Metzger; Sheri L Spunt; Xiaoping Xiong; Mathew J Krasin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-07       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.